Home » WATSON RECEIVES TENTATIVE APPROVAL FOR GENERIC SEASONALE
WATSON RECEIVES TENTATIVE APPROVAL FOR GENERIC SEASONALE
Watson Pharmaceuticals has received tentative approval today from the FDA on its abbreviated new drug application (ANDA) for levonorgestrel / ethinyl estradiol tablets USP, in 0.15 mg and 0.03 mg.
Levonorgestrel / ethinyl estradiol tablets USP is the generic equivalent to Duramed Pharmaceuticals' Seasonale tablets, which is indicated for prevention of pregnancy.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May